NL-OMON42024已完成2 期
ong-term Outcome of Children Enrolled in Study ROPP-2008-01 Previously Treated with rhIGF-1/rhIGFBP-3 for the Prevention of Retinopathy of Prematurity (ROP) or Who Received Standard Neonatal Care - Shire SHP-607-201
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- Shire
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 11（—）
入选标准
- •1. Subject was randomized in Study ROPP-2008-01, Section D
- •2. Subject*s parent or legally authorized representative(s) must provide written informed consent prior to performing any study-related activities. Study-related activities are any procedures that would not have been performed during normal management of the subject.
排除标准
- •1. Any other condition or therapy that, in the Investigator*s opinion, may pose a risk to the subject or interfere with the subject*s ability to be compliant with this protocol or interfere with the interpretation of results
- •2. The subject or subject*s parent or legally authorized representative(s) is unable to comply with the protocol as determined by the Investigator
研究者
相似试验
进行中（未招募）
1 期
ong-term Outcome of Children Enrolled in Study ROPP-2008-01 Previously Treated with rhIGF-1/rhIGFBP-3 for the Prevention of Retinopathy of Prematurity (ROP) or Who Received Standard Neonatal CareEUCTR2014-003556-31-PLPremacure AB, A Member of the Shire Group of Companies120
进行中（未招募）
1 期
ong-term Outcome of Children Enrolled in Study ROPP-2008-01 Previously Treated with rhIGF-1/rhIGFBP-3 for the Prevention of Retinopathy of Prematurity (ROP) or Who Received Standard Neonatal CareEUCTR2014-003556-31-GBPremacure AB, A Member of the Shire Group of Companies120
进行中（未招募）
1 期
ong-term Outcome of Children Enrolled in Study ROPP-2008-01 Previously Treated with rhIGF-1/rhIGFBP-3 for the Prevention of Retinopathy of Prematurity (ROP) or Who Received Standard Neonatal CareEUCTR2014-003556-31-NLPremacure AB, A Member of the Shire Group of Companies120
进行中（未招募）
1 期
ong-term Outcome of Children Enrolled in Study ROPP-2008-01 Previously Treated with rhIGF-1/rhIGFBP-3 for the Prevention of Retinopathy of Prematurity (ROP) or Who Received Standard Neonatal CareRetinopathy of Prematurity (ROP)EUCTR2014-003556-31-SEPremacure AB, A Member of the Shire Group of Companies120
进行中（未招募）
1 期
ong-term Outcome of Children Enrolled in Study ROPP-2008-01 Previously Treated with rhIGF-1/rhIGFBP-3 for the Prevention of Retinopathy of Prematurity (ROP) or Who Received Standard Neonatal CareEUCTR2014-003556-31-ITPREMACURE AB, A MEMBER OF SHIRE GROUP OF COMPANIES76